Your browser doesn't support javascript.
loading
Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951.
Mondelaers, Veerle; Suciu, Stefan; De Moerloose, Barbara; Ferster, Alina; Mazingue, Françoise; Plat, Geneviève; Yakouben, Karima; Uyttebroeck, Anne; Lutz, Patrick; Costa, Vitor; Sirvent, Nicolas; Plouvier, Emmanuel; Munzer, Martine; Poirée, Maryline; Minckes, Odile; Millot, Frédéric; Plantaz, Dominique; Maes, Philip; Hoyoux, Claire; Cavé, Hélène; Rohrlich, Pierre; Bertrand, Yves; Benoit, Yves.
Afiliação
  • Mondelaers V; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent University, Belgium veerle.mondelaers@uzgent.be.
  • Suciu S; EORTC Headquarters, Brussels, Belgium.
  • De Moerloose B; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent University, Belgium.
  • Ferster A; Department of Pediatric Hematology-Oncology, Children's University Hospital Queen Fabiola, Université Libre de Bruxelles (ULB), Belgium.
  • Mazingue F; Department of Pediatric Hematology-Oncology, CHRU, Lille, France.
  • Plat G; Department of Pediatric Hematology-Oncology, CHU-Hopital Purpan, Toulouse, France.
  • Yakouben K; Department of Pediatric Hematology, Robert Debré Hospital, AP-HP, Paris, France.
  • Uyttebroeck A; Department of Pediatric Hematology-Oncology, University Hospital Gasthuisberg, Leuven, Belgium.
  • Lutz P; Department of Pediatric Hematology-Oncology, University Hospital Hautepierre, Strasbourg, France.
  • Costa V; Department of Pediatrics, Portuguese Oncology Institute, Porto, Portugal.
  • Sirvent N; Department of Pediatric Hematology-Oncology, CHU, Montpellier, France.
  • Plouvier E; Pediatric Hematology Unit, CHU Jean Minjoz Hospital, Besançon, France.
  • Munzer M; Department of Pediatric Hematology-Oncology, American Memorial Hospital, Reims, France.
  • Poirée M; Department of Pediatric Hematology-Oncology, CHU Lenval, Nice, France.
  • Minckes O; Department of Pediatric Hematology-Oncology, CHU, Caen, France.
  • Millot F; Pediatric Oncology Unit, University Hospital, Poitiers, France.
  • Plantaz D; Department of Pediatric Oncology, University Hospital, Grenoble, France.
  • Maes P; Department of Pediatrics, University Hospital Antwerp, Belgium.
  • Hoyoux C; Department of Pediatrics, CHR de la Citadelle, Liège, Belgium.
  • Cavé H; Department of Genetics, Assistance Publique des Hôpitaux de Paris (AP-HP), Robert Debré Hospital, Paris, France.
  • Rohrlich P; INSERM UMR 1131, University Institute of Hematology, University Paris Diderot, Paris Sorbonne Cité, France.
  • Bertrand Y; Department of Pediatric Hematology-Oncology, CHU Lenval, Nice, France.
  • Benoit Y; Institute of Pediatric Hematology and Oncology (IHOP), Hospices Civils de Lyon, and University Lyon 1, France.
Haematologica ; 102(10): 1727-1738, 2017 10.
Article em En | MEDLINE | ID: mdl-28751566

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asparaginase / Linfoma não Hodgkin / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Haematologica Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asparaginase / Linfoma não Hodgkin / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Haematologica Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Itália